Compare · DHR vs MASS
DHR vs MASS
Side-by-side comparison of Danaher Corporation (DHR) and 908 Devices Inc. (MASS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and MASS operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $151.82B, about 333.9x MASS ($454.7M).
- DHR has been more active in the news (19 items in the past 4 weeks vs 13 for MASS).
- DHR has more recent analyst coverage (25 ratings vs 6 for MASS).
- Company
- Danaher Corporation
- 908 Devices Inc.
- Price
- -
- -
- Market cap
- $151.82B
- $454.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 19
- 13
- Recent ratings
- 25
- 6
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
908 Devices Inc.
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Latest DHR
- President & CEO Blair Rainer sold $12,736,095 worth of shares (58,255 units at $218.63) (SEC Form 4)
- Executive Vice President Riley Christopher Paul was granted 41,072 shares, increasing direct ownership by 201% to 61,472 units (SEC Form 4)
- SEC Form 4 filed by EVP & Chief Financial Officer Gugino Matthew E
- SEC Form 4 filed by SVP-Chief Legal Officer Leiken Jonathan
- SVP, Chief Science Officer Gutierrez-Ramos Jose-Carlos was granted 13,477 shares, increasing direct ownership by 71% to 32,495 units (SEC Form 4)
- SEC Form 4 filed by Executive Vice President Sawyer Montgomery Julie A
- SEC Form 4 filed by VP, Chief Accounting Officer Bouda Christopher
- Executive Vice President Milosevich Gregory M was granted 15,402 shares, increasing direct ownership by 170% to 24,467 units (SEC Form 4)
- Chairman of Exec. Committee Rales Mitchell P was granted 500,000 shares, increasing direct ownership by 939% to 553,228 units (SEC Form 4)
- Chairman Rales Steven M was granted 500,000 shares, increasing direct ownership by 16% to 3,605,808 units (SEC Form 4)
Latest MASS
- SEC Form 144 filed by 908 Devices Inc.
- Large owner Awm Investment Company, Inc. sold $529,797 worth of shares (50,000 units at $10.60) (SEC Form 4)
- President and CEO Knopp Kevin J. sold $283,677 worth of shares (27,622 units at $10.27) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 555,968 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by 908 Devices Inc.
- Director Brown Christopher D. sold $162,406 worth of shares (17,800 units at $9.12) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 805,559 units (SEC Form 4)
- President and CEO Knopp Kevin J. sold $1,475,145 worth of shares (149,013 units at $9.90) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 583,590 units (SEC Form 4)
- 908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
- SEC Form 10-Q filed by 908 Devices Inc.
- 908 Devices Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook